On Tuesday, Shares of J. C. Penney Company, Inc. (NYSE:JCP), lost -2.58% to $8.69.
J.C. Penney Company and legendary fashion designer Nicole Miller are celebrating a decade of nicole by Nicole Miller® designs with an anniversary collection that pays homage to a brand that appeals to millions of women across the country. The specialty creations, accessible for a limited time starting Sept. 4 in 600 stores and on jcp.com, will showcase the enduring popularity of nicole by Nicole Miller and spotlight her modern design aesthetic using eclectic prints, bold colors and sophisticated accents that have become synonymous with Nicole Miller`s signature style.
The anniversary collection is inspired by ancient cultural designs and comprises city jackets, pencil skirts, ankle pants, leggings, intarsia sweaters and sheath dresses retailing from $38 to $120. The pieces are adorned with tribal prints and gemstone patterns in jeweled tones of purple, blue and yellow on black. The standout fashion pieces feature leopard prints, black and white combinations and luxury embellishments such as intricate beading and faux fur. The anniversary collection is complete with matching handbags, earrings, necklaces and scarves. Limited edition journals and organizers are also accessible in Nicole Miller`s signature patterns.
J.C. Penney Company, Inc., through its partner, J. C. Penney Corporation, Inc., sells merchandise through department stores in the United States. The company sells family apparel and footwear, accessories, fine and fashion jewelry, beauty products, and home furnishings, in addition to provides various services, counting styling salon, optical, portrait photography, and custom decorating.
Shares of The Estée Lauder Companies Inc. (NYSE:EL), inclined 1.23% to $83.82, during its last trading session.
The Estée Lauder Companies stated financial results for its fourth quarter and fiscal year ended June 30, 2015. For the three months ended June 30, 2015, the Company stated net sales of $2.52 billion, contrast with $2.73 billion in the preceding-year period. The fiscal 2014 fourth quarter comprised of the effect of the accelerated retailer orders, which created an unfavorable comparison with the fiscal 2015 fourth-quarter results. Adjusting for the impact of the accelerated orders, net sales in constant currency for the three months ended June 30, 2015 would have raised 7%, in line with the Company’s expectations, and grew in each of the Company’s geographic regions and product categories, except skin care.
The Company’s fourth quarter sales benefited from innovative new products and growth in emerging and developed markets. The Company generated strong gains in the U.S., after adjusting for the accelerated orders, and constant currency double-digit gains in the U.K. Double-digit constant currency enhances were generated in many European emerging markets, in addition to in Asia/Pacific. The Company stated net earnings of $153.0 million, contrast with $257.7 million last year. Diluted net earnings per common share were $.40, contrast with $.66 stated in the same preceding-year period. Adjusting for the impact of the accelerated orders, diluted net earnings per common share in constant currency for the three months ended June 30, 2015 would have raised 4%.
For the year, the Company achieved net sales of $10.78 billion, a 2% decrease contrast with $10.97 billion in the preceding year. Net earnings for the year were $1.09 billion, contrast with $1.20 billion last year, and diluted net earnings per common share were $2.82, contrast with $3.06 stated in the preceding year. For the year, the negative impact of foreign currency translation on diluted net earnings per common share was $.24. Not taking into account the impact of foreign currency translation, net sales raised 3% and diluted net earnings per common share were flat. Adjusting for the impact of the accelerated orders and the charges noted below, net sales and diluted earnings per common share in constant currency for the fiscal year ended June 30, 2015 would have raised 6% and 12%, respectively.
The Estée Lauder Companies Inc. manufactures, markets, and sells skin care, makeup, fragrance, and hair care products worldwide. The company’s skin care products comprise moisturizers, serums, cleansers, toners, exfoliators, acne and oil correctors, sun care, and eye and body care products; and makeup products comprise of face, eye, lip, and nail products, in addition to related items, such as compacts, brushes, and other makeup tools.
Finally, Baxalta Incorporated (NYSE:BXLT), ended its last trade with -1.07% loss, and closed at $39.92, hitting its highest level.
Baxalta Incorporated wants Shire to improve on its $30 billion bid significantly before it will engage in talks, while its Dublin-based rival could sweeten its offer if it gets to see the U.S. biotech company’s books, according to sources on both sides, according to Reuters.
After a series of meetings with major shareholders on both sides, Shire believes the argument about industrial logic is close to being settled. Reuters Reports
Baxalta Incorporated, a biopharmaceutical company, develops, manufactures, and markets a portfolio of products primarily for the treatment of hematology and immunology worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
